Readmissions Rates After Myocardial Infarction for Gastrointestinal Bleeding: A National Perspective

Kamesh Gupta1, Ahmad Khan2, Manish Kumar3

  • 1Department of Internal Medicine, UMMS-Baystate Medical Center, Springfield, MA, USA. Kameshg9@gmail.com.

Insights

Gastrointestinal bleeding affects 0.3% of patients after acute myocardial infarction (AMI), leading to significant mortality and healthcare costs. Predictors include age and comorbidities, but AMI treatment type did not influence readmission risk.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Health Services Research

Background:

  • Gastrointestinal (GI) bleeding is a frequent complication following acute myocardial infarction (AMI).
  • Understanding the incidence, outcomes, and predictors of GI bleeding post-AMI is crucial for patient management and resource allocation.

Purpose of the Study:

  • To determine the 30-day incidence of GI bleeding after AMI.
  • To investigate in-hospital outcomes, healthcare burden, and predictors of GI bleeding readmission within 30 days of AMI.

Main Methods:

  • Utilized data from the Nationwide Readmission Database (2010-2014).
  • Included patients with ST or non-ST elevation myocardial infarction, excluding specific criteria.
  • Analyzed 30-day readmissions for upper or lower GI bleeding, in-hospital mortality, complications, procedures, length of stay, and hospitalization charges using multivariate logistic regression.

Main Results:

  • 0.3% of 3,520,241 patients discharged with AMI were readmitted with GI bleeding within 30 days.
  • Lower GI bleeding was more common (60%), with GI cancers and hemorrhoids as suspected sources.
  • In-hospital mortality for readmissions was 3.6%; predictors included age, comorbidities (CKD, GI tumor, IBD), and artificial heart valve. AMI treatment type did not impact readmission.

Conclusions:

  • The 30-day incidence of GI bleeding after AMI is 0.3% in the US.
  • GI bleeding complicating AMI results in considerable in-hospital mortality and significant healthcare costs.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
159
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
689
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
142